Screener
Agios Pharmaceuticals AGIO Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Agios Pharmaceuticals’s reported figures.
Based on the most recent quarter.
The source filing: Agios Pharmaceuticals’s 10-Q, filed July 30, 2026. Open the filing →
- Filed
- Jul 30, 2026, 9:56 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001439222-26-000118
FAQ
- What is Agios Pharmaceuticals's current ratio?
- Agios Pharmaceuticals (AGIO) reported current ratio of 10.2× in Q2 2026.
- How has Agios Pharmaceuticals's current ratio changed year-over-year?
- Agios Pharmaceuticals's current ratio decreased by 29.4% year-over-year, from 14.5× to 10.2×.
- What is the long-term trend for Agios Pharmaceuticals's current ratio?
- Over 5 years (2020 to 2025), Agios Pharmaceuticals's current ratio has grown at a 11.2% compound annual growth rate (CAGR), from 6.7× to 11.5×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.
Ask your AI about Agios Pharmaceuticals's current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude